Related references
Note: Only part of the references are listed.High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
Masaki Nasu et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma
Katie A. Matatall et al.
BMC CANCER (2013)
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
Payal Kapur et al.
LANCET ONCOLOGY (2013)
Prognostic significance of BRCA1-associated protein 1 in colorectal cancer
Jianjun Tang et al.
MEDICAL ONCOLOGY (2013)
BAP1 loss defines a new class of renal cell carcinoma
Samuel Pena-LlopiS et al.
NATURE GENETICS (2012)
Deubiquitinases in cancer: new functions and therapeutic options
J. M. Fraile et al.
ONCOGENE (2012)
BAP1 is a good prognostic factor in advanced non-small cell lung cancer
Li-hong Fan et al.
CLINICAL AND INVESTIGATIVE MEDICINE (2012)
Vimentin in cancer and its potential as a molecular target for cancer therapy
Arun Satelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling
Jian Liang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The New Lung Cancer Staging System
Frank C. Detterbeck et al.
CHEST (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization
Karen H. Ventii et al.
CANCER RESEARCH (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
Y Shou et al.
BRITISH JOURNAL OF CANCER (2001)
Impairment of the ubiquitin-proteasome system by protein aggregation
NF Bence et al.
SCIENCE (2001)
Share Paper
